Short-Term Debt to Equity Ratio: NeuroBo Pharmaceuticals (NRBO)
NeuroBo Pharmaceuticals (NRBO) is expanding its portfolio of treatments for MASH and metabolic disorders to secure future dominance in neuropharmaceuticals, a trend reflected in the chart with a market price currently at 0.01. However, global conflicts and sanctions are hindering international trials and the supply of biomaterials. Development stability is maintained through the creation of strategic reserves of chemical components to eliminate logistics disruptions.
neurobopharma.com (NRBO) - metric breakdowns and financial figures
- stock quotes and analyst forecast:
- company stock exchange capitalization indicators:
- issuer book value statistics:
- company liabilities and liquidity data:
Debt to Equity NeuroBo Pharmaceuticals|NRBO - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital NeuroBo Pharmaceuticals, Inc.|NRBO - Company Cumulative Debt|Debt to Book Value NeuroBo Pharmaceuticals Inc|NRBO - Company Long-Term Debts|Company Short-Term Debt NeuroBo Pharmaceuticals|Quick Liquidity neurobopharma.com
- company profitability and valuation multiples indicators:
Analysis of all company metrics:NeuroBo NRBO
Striving for FDA approval while remaining dependent on a Korean majority shareholder, NeuroBo Pharmaceuticals (NRBO) utilizes borrowed funds to finance clinical stages, where the ratio of short-term liabilities (up to one year) to equity reflects the degree of financial risk and expansion aggressiveness, allowing investors to assess the company's vulnerability to rising interest rates via a short-term debt-to-equity ratio chart.
Analysis of competing companies
Short-Term Debt to Capital BIIB|NBIX - Current Liabilities to Capital|Regencell Bioscience - Short-Term Debt to Equity Ratio|Short-Term Debt to Capital axsome.com AXSM|ACAD - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital XENE (Xenon Pharmaceuticals Inc.)|Viking Pharma (VKTX) - Short-Term Debt to Equity|Current Liabilities to Capital Supernus Corp (SUPN)|Short-Term Debt to Equity Catalyst Pharmaceuticals|Short-Term Debt to Capital Ratio DNLI (denalitherapeutics.com)|Short-Term Debt to Capital HRMY|BHVN - Current Liabilities to Capital|Amylyx - Short-Term Debt to Equity Ratio|Short-Term Debt to Capital Trevi Corp TRVI|PRAX - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital AVXL (anavex.com)|CeriBell (CBLL) - Short-Term Debt to Equity|Current Liabilities to Capital Prothena Biosciences (PRTA)|ALEC (Alector Inc.) - Short-Term Debt to Capital|Short-Term Debt to Equity ANNX|Short-Term Debt to Equity Omeros Corporation (OMER)|NGNE - Current Liabilities to Capital|AC Immune SA - Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital VYGR|NMRA - Short-Term Debt to Equity|Current Liabilities to Equity SCLX|TVGN: Short-Term Debt to Capital|Alpha Cognition Inc. - Ratio of Short-Term Indebtedness to Capital|CGTX (Cognition Therapeutics, Inc.) - Short-Term Debt to Capital|Short-Term Debt to Capital Inhibikase Therapeutics Inc|Short-Term Debt to Equity Cassava (SAVA)|ASRT (assertiotx.com) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Coya Therapeutics COYA|VTGN - Short-Term Debt to Equity Ratio|Ovid Rx - Short-Term Debt to Capital|ABOS - Short-Term Debt to Capital|CRVO: Short-Term Debt to Capital|Short-Term Debt to Equity Ratio Alterity Therapeutics Limited|CLNN (Clene Inc) - Short-Term Debt to Capital|Current Liabilities to Capital PepGen Corp PEPG|Short-Term Debt to Equity Ratio JUNS (Jupiter Neurosciences)|Short-Term Debt to Capital Relmada Therapeutics Inc (RLMD)|Annovis Bio Corp - Short-Term Debt to Equity Ratio|Short-Term Loans to Capital Ratio GRCE (Grace Therapeutics Inc)|Firefly Neuroscience, Inc - Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient Klotho Neurosciences Inc KLTO|NRSN: Short-Term Debt to Capital|Short-Term Debt to Equity Ratio Reviva Pharmaceuticals Holdings Inc.|MTVA (MetaVia Inc.) - Short-Term Debt to Capital|Short-Term Debt to Capital NeurAxis Inc|Short-Term Debt to Equity Helius Medical (HSDT)|Short-Term Debt to Equity PASG (passagebio.com)|Short-Term Debt to Equity Neuphoria Therapeutics NEUP|Short-Term Debt to Capital Coefficient Minerva Neurosciences Inc (NERV)|ATHA - Short-Term Debt to Equity|ADXN (Addex) - Short-Term Debt to Capital Ratio|alzamend.com (ALZN) - Short-Term Debt to Equity|Cyclerion Therapeutics, Inc. - Ratio of Short-Term Indebtedness to Capital|PTIX (Protagenic Therapeutics Inc.) - Short-Term Debt to Capital|Short-Term Debt to Equity KTTA|Short-Term Debt to Equity Cortigent, Inc. (CRGT)|ATXI - Current Liabilities to Capital|Short-Term Debt to Equity Brainstorm Cell BCLI|CARA: Short-Term Debt to Capital Ratio|Chromocell Therapeutics Corp. - Short-Term Debt to Capital|Current Liabilities to Capital Eliem Therapeutics|ITCI (intracellulartherapies.com) - Short-Term Debt to Equity Ratio|Longboard (LBPH) - Short-Term Debt to Capital|Short-Term Debt to Equity Marinus Pharmaceuticals|NKGN: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Sage Therapeutics (SAGE)|SNPX - Current Liabilities to Capital|Short-Term Debt to Equity Trevena, Inc TRVN|VIGL: Short-Term Debt to Capital Ratio|Anew Medical, Inc. - Short-Term Debt to Capital|Current Liabilities to Capital cerevel.com